DE69225625D1 - Carbaminsäurederivate und Verfahren zu ihrer Herstellung - Google Patents

Carbaminsäurederivate und Verfahren zu ihrer Herstellung

Info

Publication number
DE69225625D1
DE69225625D1 DE69225625T DE69225625T DE69225625D1 DE 69225625 D1 DE69225625 D1 DE 69225625D1 DE 69225625 T DE69225625 T DE 69225625T DE 69225625 T DE69225625 T DE 69225625T DE 69225625 D1 DE69225625 D1 DE 69225625D1
Authority
DE
Germany
Prior art keywords
preparation
acid derivatives
carbamic acid
carbamic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69225625T
Other languages
English (en)
Other versions
DE69225625T2 (de
Inventor
Yasuo Takano
Masanori Takadoi
Takashi Hirayama
Atsuhiro Yamanishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of DE69225625D1 publication Critical patent/DE69225625D1/de
Application granted granted Critical
Publication of DE69225625T2 publication Critical patent/DE69225625T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
DE69225625T 1991-01-31 1992-01-29 Carbaminsäurederivate und Verfahren zu ihrer Herstellung Expired - Fee Related DE69225625T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3192291 1991-01-31
JP03007192A JP3169188B2 (ja) 1991-01-31 1992-01-21 カルバミン酸誘導体及びその製造方法

Publications (2)

Publication Number Publication Date
DE69225625D1 true DE69225625D1 (de) 1998-07-02
DE69225625T2 DE69225625T2 (de) 1999-01-28

Family

ID=26368350

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69225625T Expired - Fee Related DE69225625T2 (de) 1991-01-31 1992-01-29 Carbaminsäurederivate und Verfahren zu ihrer Herstellung

Country Status (10)

Country Link
EP (1) EP0497303B1 (de)
JP (1) JP3169188B2 (de)
KR (1) KR960009429B1 (de)
CN (1) CN1054123C (de)
AU (1) AU643590B2 (de)
CA (1) CA2060393C (de)
DE (1) DE69225625T2 (de)
ES (1) ES2118094T3 (de)
HU (2) HU222246B1 (de)
TW (1) TW199889B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0522914A1 (de) * 1991-06-27 1993-01-13 Synthelabo 2-Piperidinylpyrimidin-4-Carboxamidderivate, deren Herstellung und deren Verwendung als Heilmittel
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
DE19750401A1 (de) * 1997-11-14 1999-05-20 Bayer Ag Kondensierte Pyridin-Derivate
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB0218326D0 (en) * 2002-08-07 2002-09-11 Glaxo Group Ltd Compounds
KR100477987B1 (ko) 2002-09-11 2005-03-23 삼성에스디아이 주식회사 리튬-황 전지용 양극 및 이를 포함하는 리튬-황 전지
US20070004763A1 (en) * 2005-06-10 2007-01-04 Nand Baindur Aminoquinoline and aminoquinazoline kinase modulators
FR2948368B1 (fr) * 2009-07-21 2011-07-22 Servier Lab Nouveaux composes piperidiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY36391A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (de) * 1977-06-03 1981-03-07 Pfizer
GB2021108B (en) * 1978-05-18 1982-07-21 Pfizer Ltd 6,7 - di - 4 - amino - 2 - quinazolines
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
JPS63170356A (ja) * 1986-12-30 1988-07-14 Yamanouchi Pharmaceut Co Ltd アニリン誘導体及びその製造法

Also Published As

Publication number Publication date
CN1054123C (zh) 2000-07-05
KR920014798A (ko) 1992-08-25
JPH0558999A (ja) 1993-03-09
AU643590B2 (en) 1993-11-18
ES2118094T3 (es) 1998-09-16
CA2060393C (en) 2002-03-12
CN1064075A (zh) 1992-09-02
AU1064992A (en) 1992-08-06
KR960009429B1 (en) 1996-07-19
HU222246B1 (hu) 2003-05-28
EP0497303A2 (de) 1992-08-05
EP0497303A3 (en) 1992-09-23
JP3169188B2 (ja) 2001-05-21
EP0497303B1 (de) 1998-05-27
HUT60260A (en) 1992-08-28
HU9200251D0 (en) 1992-04-28
CA2060393A1 (en) 1992-08-01
DE69225625T2 (de) 1999-01-28
TW199889B (de) 1993-02-11

Similar Documents

Publication Publication Date Title
DE69225631D1 (de) Acylaminosäure-Verbindungen und Verfahren zu ihrer Herstellung
ATA902992A (de) Antigeschwulstmittel und verfahren zu ihrer herstellung
DE69211697T2 (de) Antischmelzsicherungsstruktur und verfahren zu ihrer herstellung
DE69210067T2 (de) Hydraxamsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69411604D1 (de) Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung
DE69302810D1 (de) Verbundwerkstoffe und verfahren zu ihrer herstellung
DE69522372D1 (de) Polyasparaginsäurederivate und Verfahren zu ihrer Herstellung
DE69225625T2 (de) Carbaminsäurederivate und Verfahren zu ihrer Herstellung
DE69123667T2 (de) 1,4-Dihydropyridin-Derivate und Verfahren zu ihrer Herstellung
DE69306279D1 (de) 3-Aryl-Glycidsäureester und Verfahren zu ihrer Herstellung
DE69121284T2 (de) Polyanilinderivate und Verfahren zu ihrer Herstellung
DE69017091T2 (de) Cyclomalto-oligosaccharidderivate und Verfahren zu ihrer Herstellung.
DE59206999D1 (de) Oxadimethacryl-Verbindungen und Verfahren zu ihrer Herstellung
DE59306753D1 (de) Thiocarbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung
DE69212920T2 (de) Oligohexafluoropropylenverbindungen und Verfahren zu ihrer Herstellung
AT399879B (de) Dihydro-pyrimido-thiazin-derivate und verfahren zu ihrer herstellung
DE69116829T2 (de) Wasserlösliche Thioharnstoffdioxidderivate und Verfahren zu ihrer Herstellung
DE68914500T2 (de) Alkylarylsulfone und Verfahren zu ihrer Herstellung.
DE59403693D1 (de) 4-Alkyl-3-chlor-benzolsulfinsäuren,4-Alkyl-3-chlor-benzolsulfonylcarbonsäuren, 4-Alkyl-3-chlor-alkylsulfonylbenzole und Verfahren zu ihrer Herstellung
DE3880904T2 (de) Weinsäureamidderivate und Verfahren zu ihrer Herstellung.
AT399505B (de) 2-methyl-3-rhodanido-propionsäure und verfahren zu ihrer herstellung
DE69325602T2 (de) Gamma-Polyglutaminsäure-Hydrolase und Verfahren zu ihrer Herstellung
DE69528860D1 (de) 1-Amino-2-Cyclohexenderivate und Verfahren zu ihrer Herstellung
ATA123792A (de) Artilleriegranate und verfahren zu ihrer herstellung
DE68914813D1 (de) 2-Acylamino-5-Halogen-Zimtsäurederivate und Verfahren zu ihrer Herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee